Wayne Arthur Jensen
Veterinary in Wellington, CO
License number
Colorado 4125
Issued Date
Jun 8, 1984
Renew Date
Nov 1, 2016
Expiration Date
Oct 31, 2018
Type
Veterinarian
Address
Address
9133 Ncr 5, Wellington, CO 80549
Personal information
See more information about Wayne Arthur Jensen at radaris.comName
Address
Phone
5179 Belle Star Dr, Colorado Springs, CO 80922
7721 S Kalispell Ct, Englewood, CO 80112
Professional information
Haemobartonella Pcr Methods And Materials
US Patent:
6558909, May 6, 2003
Filed:
Aug 10, 2001
Appl. No.:
09/927904
Inventors:
Wayne A. Jensen - Wellington CO
Assignee:
Heska Corporation - Fort Collins CO
International Classification:
C12Q 168
US Classification:
435 6, 435 912, 536 237, 536 2432, 536 2433
Abstract:
In broad terms, the present invention includes materials and methods useful to distinguish between and among species of a genus. The present methods utilize the differences in PCR amplicon sizes to specifically identify a given species.
Haemobartonella Pcr Methods And Materials
US Patent:
6518020, Feb 11, 2003
Filed:
Sep 17, 1999
Appl. No.:
09/398577
Inventors:
Wayne Jensen - Wellington CO
Assignee:
Heska Corporation - Fort Collins CO
International Classification:
C12Q 168
US Classification:
435 6, 435 912, 536 237, 536 2432, 536 2433
Abstract:
In broad terms, the present invention includes materials and methods useful to distinguish between and among species of a genus. The present methods utilize the differences in PCR amplicon sizes to specifically identify a given species.
Kits Ands Compositions For The Detection Of Haemobartonella
US Patent:
6759531, Jul 6, 2004
Filed:
Mar 27, 2003
Appl. No.:
10/401337
Inventors:
Wayne A. Jensen - Wellington CO 80549
International Classification:
C07H 2104
US Classification:
536 2433, 536 237, 536 2432, 435 6, 435 912, 435810
Abstract:
In broad terms, the present invention includes materials and methods useful to distinguish between and among species of a genus. The present methods utilize the differences in PCR amplicon sizes to specifically identify a given species.
Use Of Recombinant Antigens To Determine The Immune Status Of An Animal
US Patent:
2008028, Nov 20, 2008
Filed:
May 29, 2008
Appl. No.:
12/128862
Inventors:
Wayne A. Jensen - Wellington CO, US
Michael R. Lappin - Fort Collins CO, US
David K. Rosen - Portage MI, US
Janet S. Andrews - Fort Collins CO, US
Michael R. Lappin - Fort Collins CO, US
David K. Rosen - Portage MI, US
Janet S. Andrews - Fort Collins CO, US
International Classification:
A61K 39/00, A61P 37/00
US Classification:
4241871, 4241841, 4242041, 4242131, 4242311, 4242241, 4242331, 4241861, 4242071
Abstract:
The present invention includes a method to determine the immune status of an animal that includes the steps of (a) contacting a biological specimen of the animal with a recombinant infectious agent antigen that is specific for detecting an antibody selective for that infectious agent, under conditions suitable for formation of a complex between the recombinant antigen and the antibody and (b) detecting the presence or absence of the complex, wherein presence or absence of a complex is indicative of the immune status of the animal. Preferably such a method indicates whether the animal should be vaccinated. The present invention also includes an assay comprising (a) a recombinant infectious agent antigen that is specific for detecting an antibody selective for that infectious agent; and (b) a means to detect an antibody that selectively binds to the recombinant antigen. Also included in the present invention are recombinant antigens and nucleic acid molecules encoding such antigens as well as methods to produce and use such nucleic acid molecule and recombinant antigens.
Use Of Recombinant Antigens To Determine The Immune Status Of An Animal
US Patent:
2004005, Mar 25, 2004
Filed:
Sep 25, 2003
Appl. No.:
10/670695
Inventors:
Wayne Jensen - Wellington CO, US
Michael Lappin - Fort Collins CO, US
David Rosen - Portage MI, US
Janet Andrews - Fort Collins CO, US
Michael Lappin - Fort Collins CO, US
David Rosen - Portage MI, US
Janet Andrews - Fort Collins CO, US
International Classification:
C12Q001/70, G01N033/554, G01N033/569
US Classification:
435/005000, 435/007320
Abstract:
The present invention includes a method to determine the immune status of an animal that includes the steps of (a) contacting a biological specimen of the animal with a recombinant infectious agent antigen that is specific for detecting an antibody selective for that infectious agent, under conditions suitable for formation of a complex between the recombinant antigen and the antibody and (b) detecting the presence or absence of the complex, wherein presence or absence of a complex is indicative of the immune status of the animal. Preferably such a method indicates whether the animal should be vaccinated. The present invention also includes an assay comprising (a) a recombinant infectious agent antigen that is specific for detecting an antibody selective for that infectious agent; and (b) a means to detect an antibody that selectively binds to the recombinant antigen. Also included in the present invention are recombinant antigens and nucleic acid molecules encoding such antigens as well as methods to produce and use such nucleic acid molecule and recombinant antigens.
Pcr Methods And Materials For Detecting Bartonella Species
US Patent:
6300072, Oct 9, 2001
Filed:
Sep 17, 1999
Appl. No.:
9/398179
Inventors:
Wayne Jensen - Wellington CO
Assignee:
Heska Corporation - Fort Collins CO
International Classification:
C12Q 168, C12P 1934, C01H 2104
US Classification:
435 6
Abstract:
In broad terms, the present invention includes materials and methods useful to distinguish between and among species of a genus. The present methods utilize the differences in PCR amplicon sizes to specifically identify a given species.
Methods Of Detecting Early Renal Disease In Animals
US Patent:
7935495, May 3, 2011
Filed:
Jan 26, 2007
Appl. No.:
11/627784
Inventors:
Thomas McDonald - Omaha NE, US
Wayne Arthur Jensen - Wellington CO, US
Annika Weber - Omaha NE, US
Janet S. Andrews - Fort Collins CO, US
Wayne Arthur Jensen - Wellington CO, US
Annika Weber - Omaha NE, US
Janet S. Andrews - Fort Collins CO, US
Assignee:
Heska Corporation - Loveland CO
International Classification:
G01N 31/00, G01N 33/53
US Classification:
435 721, 435 71, 436 1, 436501, 436518, 424 91, 424520, 422 1, 422 50, 530300, 530350
Abstract:
The present invention provides a method for the detection of early renal disease in animals. The method includes the steps of (a) obtaining a sample from an animal to be tested and (b) determining the amount of albumin in the sample. An amount of albumin in the range of from 10 μg/ml to about 300 μg/ml indicates the presence of early renal disease. The present invention also provides antibodies to canine, feline and equine albumin which can be used to detect the presence of early renal disease.
Anti-Feline Albumin Antibodies
US Patent:
7482128, Jan 27, 2009
Filed:
Mar 25, 2004
Appl. No.:
10/550563
Inventors:
Wayne A. Jensen - Wellington CO, US
Shirley Wu Hunter - Fort Collins CO, US
Karen Sverlow - Dixon CA, US
Janet S. Andrews - Westminster CO, US
Shirley Wu Hunter - Fort Collins CO, US
Karen Sverlow - Dixon CA, US
Janet S. Andrews - Westminster CO, US
Assignee:
Heska Corporation - Loveland CO
International Classification:
G01N 33/53
US Classification:
435 71, 435 72, 435 791, 435 792, 436516, 436518
Abstract:
The present invention provides isolated monoclonal antibodies that selectively bind albumin from animals. Also provided are methods using such antibodies for the detection of early renal disease in animals. The method includes the steps of (a) obtaining a sample from an animal to be tested; (b) contacting the sample with an antibody having a greater avidity for feline albumin than for other proteins or components in the sample; (c) detecting the complex formed by the antibody and albumin; and (d) determining the amount of albumin in the sample from the amount of antibody-albumin complex detected. An amount of albumin in the range of from 10 μg/ml to about 300 μg/ml indicates the presence of early renal disease.
Methods Of Detecting Early Renal Disease In Animals
US Patent:
7172873, Feb 6, 2007
Filed:
Mar 28, 2002
Appl. No.:
10/112648
Inventors:
Thomas McDonald - Omaha NE, US
Wayne Arthur Jensen - Wellington CO, US
Annika Weber - Omaha NE, US
Janet S. Andrews - Fort Collins CO, US
Wayne Arthur Jensen - Wellington CO, US
Annika Weber - Omaha NE, US
Janet S. Andrews - Fort Collins CO, US
Assignee:
Heska Corporation - Loveland CO
International Classification:
G01N 33/53
US Classification:
435 71, 435 792, 436518, 436517, 436808, 436815
Abstract:
The present invention provides a method for the detection of early renal disease in animals. The method includes the steps of (a) obtaining a sample from an animal to be tested and (b) determining the amount of albumin in the sample. An amount of albumin in the range of from 10 μg/ml to about 300 μg/ml indicates the presence of early renal disease. The present invention also provides antibodies to canine, feline and equine albumin which can be used to detect the presence of early renal disease.
Canine Tag1 Proteins, Nucleic Acid Molecules, And Uses Thereof
US Patent:
2002009, Jul 25, 2002
Filed:
Jul 30, 2001
Appl. No.:
09/918063
Inventors:
Eric Weber - Fort Collins CO, US
Wayne Jensen - Wellington CO, US
Ramaswamy Chandrashekar - Fort Collins CO, US
Wayne Jensen - Wellington CO, US
Ramaswamy Chandrashekar - Fort Collins CO, US
International Classification:
C12P021/02, C12Q001/68, G01N033/53, C12N009/00, C12N007/00, C12N005/06, C12N015/86
US Classification:
435/069100, 435/183000, 435/006000, 435/007100, 435/350000, 536/023200, 435/235100, 435/456000, 530/388100
Abstract:
The present invention relates to canine TAg1 proteins; to canine TAg1 nucleic acid molecules, including those that encode such TAg1 proteins; to antibodies raised against such TAg1 proteins; and to compounds that inhibit TAg1 activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are compositions and methods for detecting the presence of TAg1 protein or anti-TAg1 antibodies in an animal. The present invention also includes therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to protect animals from disease.